In CRC, KDM4A promotes cell proliferation by interacting with p53 and reducing the transcription of p21, and the further study found that KDM4A sensitizes chemotherapy-induced cell death in both p53-dependent and p53-independent ways.110. Here, KDM4A is linked to colorectal carcinoma.